FHA
CLLS

First Horizon Advisors’s Cellectis CLLS Stock Holding History

First Horizon Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-33
Closed – – 2287
2021
Q2 		$0 Sell
33
-54
-62% -$908 ﹤0.01% 1984
2021
Q1 		$1K Buy
+87
New +$2.15K ﹤0.01% 1755

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

First Horizon Advisors's CLLS Position: Q3 2021 in Review

First Horizon Advisors sold out of Cellectis (CLLS) in Q3 2021, closing a stake of 33 shares.

First Horizon Advisors first reported a position in CLLS in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 70 funds tracked by Wall St. Rank hold CLLS as of Q3 2021.

  • First Horizon Advisors reported no remaining Cellectis position as of Q3 2021 after selling out during the quarter.
  • First Horizon Advisors sold 33 Cellectis shares in Q3 2021.
  • First Horizon Advisors first reported a position in Cellectis in Q1 2021 and held it in 2 quarters.
  • First Horizon Advisors's Cellectis position peaked at $1K in Q1 2021.
  • 70 funds tracked by Wall St. Rank held Cellectis as of Q3 2021.

Based on First Horizon Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.